Total Payments
$960.18
2019 Payments
$122.04
Companies
7
Transactions
10
Medicare Patients
1,223
Medicare Billing
$141,492
Payment Breakdown by Category
Food & Beverage$564.18 (58.8%)
Consulting$389.00 (40.5%)
Education$7.00 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $564.18 | 8 | 58.8% |
| Consulting Fee | $389.00 | 1 | 40.5% |
| Education | $7.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $430.70 | 2 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $137.22 | 2 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $123.01 | 1 | $0 (2018) |
| GENZYME CORPORATION | $122.04 | 1 | $0 (2019) |
| Genentech USA, Inc. | $74.03 | 1 | $0 (2017) |
| Shire North American Group Inc | $50.41 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $22.77 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $122.04 | 1 | GENZYME CORPORATION ($122.04) |
| 2018 | $180.71 | 3 | Regeneron Healthcare Solutions, Inc. ($123.01) |
| 2017 | $657.43 | 6 | AstraZeneca Pharmaceuticals LP ($430.70) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $122.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $123.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/06/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2018 | Shire North American Group Inc | CINRYZE (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2017 | Shire North American Group Inc | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2017 | Teva Pharmaceuticals USA, Inc. | CINQAIR (Drug) | Food and Beverage | In-kind items and services | $130.22 | General |
| Category: Respiratory | ||||||
| 05/15/2017 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $7.00 | General |
| 03/29/2017 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $389.00 | General |
| 02/23/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $74.03 | General |
| 01/31/2017 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $41.70 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 251 | 697 | $84,064 | $23,008 |
| 2021 | 14 | 528 | 3,392 | $239,780 | $70,041 |
| 2020 | 10 | 444 | 2,432 | $176,705 | $48,443 |
Total Patients
1,223
Total Services
6,521
Medicare Billing
$141,492
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 81 | $28,593 | $8,157 | 28.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 20 | 370 | $21,090 | $5,831 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 71 | $17,040 | $4,106 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 15 | $7,125 | $2,126 | 29.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 13 | $1,781 | $1,301 | 73.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 53 | 125 | $6,125 | $1,207 | 19.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 22 | $2,310 | $280.15 | 12.1% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 64 | 1,276 | $70,180 | $20,809 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 93 | 124 | $42,532 | $14,136 | 33.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 149 | $34,717 | $11,614 | 33.5% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 71 | 362 | $17,376 | $4,122 | 23.7% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 29 | 912 | $22,800 | $3,947 | 17.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 28 | 32 | $4,256 | $3,137 | 73.7% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2021 | 21 | 260 | $8,580 | $2,416 | 28.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $7,150 | $2,356 | 33.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $8,352 | $1,953 | 23.4% |
| 95018 | Allergy testing with drugs or biologicals into or within the skin, immediate type reaction, including test interpretation and report | Office | 2021 | 12 | 75 | $6,675 | $1,517 | 22.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 22 | 27 | $2,484 | $1,439 | 57.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $4,472 | $1,102 | 24.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 21 | 72 | $7,560 | $1,011 | 13.4% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 16 | 63 | $2,646 | $480.05 | 18.1% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 62 | 1,213 | $66,715 | $18,068 | 27.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 135 | 179 | $40,275 | $11,487 | 28.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 51 | $16,779 | $4,894 | 29.2% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 85 | 410 | $19,680 | $3,975 | 20.2% |
About Dr. Steven Rubinstein, M.D
Dr. Steven Rubinstein, M.D is a Allergy healthcare provider based in Mountain View, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083664593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Rubinstein, M.D has received a total of $960.18 in payments from pharmaceutical and medical device companies, with $122.04 received in 2019. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($564.18).
As a Medicare-enrolled provider, Rubinstein has provided services to 1,223 Medicare beneficiaries, totaling 6,521 services with total Medicare billing of $141,492. Data is available for 3 years (2020–2022), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy
- Location Mountain View, CA
- Active Since 05/12/2006
- Last Updated 11/23/2011
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1083664593
Products in Payments
- CINQAIR (Drug) $130.22
- DUPIXENT DUPILUMAB INJECTION (Biological) $123.01
- DUPIXENT (Drug) $122.04
- CINRYZE (Drug) $34.93
- NUCALA (Biological) $22.77
- CUVITRU (Biological) $15.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.